Predictors of high-dose antipsychotic prescription in psychiatric patients in Hong Kong

Hong Kong Medical Journal

Volumn 14, Issue 1, 2008, Pages 35-39

  Hung, Gabriel B K ^a   Cheung, H K ^a  

^a CASTLE PEAK HOSPITAL   (Hong Kong)

Author keywords

Antipsychotic agents; Risk factors

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; DRUG MEGADOSE; FEMALE; HONG KONG; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL PATIENT; OUTPATIENT; POLYPHARMACY; PREDICTOR VARIABLE; PRESCRIPTION; RETROSPECTIVE STUDY; AGE; CLINICAL PRACTICE; DRUG USE; MIDDLE AGED; SEX DIFFERENCE; STATISTICS;

ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; DRUG UTILIZATION REVIEW; FEMALE; HONG KONG; HUMANS; INPATIENTS; MALE; MENTAL DISORDERS; MIDDLE AGED; OUTPATIENTS; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 41649121914     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Harrington M, Lelliott P, Paton C, Okocha C, Duffett R, Sensky T. The results of a multi-centre audit of the prescribing of antipsychotic drugs for inpatients in the UK. Psychiatr Bull R Coll Psychiatr 2002;26:414-8.
2. Consensus statement on the use of high-dose antipsychotic medication. Council Report CR138. London: Royal College of Psychiatrists; 2006.
3. Practice guidelines for the treatment of patients with schizophrenia. Washington, DC: American Psychiatric Association; 2004.
4. Canadian clinical practice guidelines for the treatment of schizophrenia. The Canadian Psychiatric Association. Can J Psychiatry 1998;43(Suppl 2):25S-40S.
5. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 2005;39:1-30.
6. Clinical practice guidelines for schizophrenia in Hong Kong. Hong Kong SAR: Hospital Authority; 2004.
7. Paton C, Lelliott P. The use of prescribing indicators to measure the quality of care in psychiatric inpatients. Qual Saf Health Care 2004;13:40-5.
8. Davis JM, Chen N. Dose response and dose equivalence of antipsychotics. J Clin Psychopharmacol 2004;24:192-208.
9. Freudenreich O, Goff DC. Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psychiatr Scand 2002;106:323-30.
10. Baldessarini RJ, Cohen BM, Teicher MH. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychosis. Arch Gen Psychiatry 1988;45:79-91.
11. Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001;158:1774-82.
12. Waddington JL, Youssef HA, Kinsella A. Mortality in schizophrenia: Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study. Br J Psychiatry 1998;173:325-9.
13. Joukamaa M, Heliövaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Schizophrenia, neuroleptic medication and mortality. Br J Psychiatry 2006;188:122-7.
14. American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry 2004;65:267-72.
15. Sernyak MJ, Leslie DL, Alarcon RD, Losonczy MF, Rosenheck R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 2002;159:561-6.
16. Lelliott P, Paton C, Harrington M, Konsolaki T, Sensky T, Okocha C. The influence of patient variables on polypharmacy and combined high dose of antipsychotic drugs prescribed for inpatients. Psychiatr Bull R Coll Psychiatr 2002;26:411-4.
17. Chaplin R, McGuigan S. Antipsychotic dose: from research to clinical practice. Psychiatr Bull R Coll Psychiatr 1996;20:452-4.
18. Bitter I, Chou JC, Ungvari GS, et al. Prescribing for inpatients with schizophrenia: an international multi-center comparative study. Pharmacopsychiatry 2003;36:143-9.
19. Wilkie A, Preston N, Wesby R. High dose neuroleptics-who gives them and why? Psychiatr Bull R Coll Psychiatr 2001;25:179-83.
20. Ito H, Koyama A, Higuchi T. Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription. Br J Psychiatry 2005;187:243-7.
21. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Description and Diagnostic Guidelines. Geneva: World Health Organization; 1992.
22. British Medical Association & Royal Pharmaceutical Society of Great Britain. British National Formulary (51st edition). London & Wallingford: BMJ Books & Pharmaceutical Press; 2006.
23. Yorston G, Pinney A. Chlorpromazine equivalents and percentage of British National Formulary maximum recommended dose in patients receiving high-dose antipsychotics. Psychiatr Bull R Coll Psychiatr 2000;24:130-2.
24. Hung GB. A comparison of two methods for calculating total antipsychotic dose. Hong Kong J Psychiatry 2007;17:87-90.
25. Sim K, Su A, Leong JY, et al. High dose antipsychotic use in schizophrenia: findings of the REAP (Research on East Asia Psychotropic Prescriptions) study. Pharmacopsychiatry 2004;37:175-9.
26. Barbui C, Nose M, Mazzi MA, et al. Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries. Int Clin Psychopharmacol 2006;21:355-62.
27. Tibaldi G, Munizza C, Bollini P, Pirfo E, Punzo F, Gramaglia F. Utilization of neuroleptic drugs in Italian mental health services: a survey in Piedmont. Psychiatr Serv 1997;48:213-7.
28. Harrington M, Lelliott P, Paton C, Konsolaki T, Sensky T, Okocha C. Variation between services in polypharmacy and combined high dose of antipsychotic drugs prescribed for inpatients. Psychiatr Bull R Coll Psychiatr 2002;26:418-20.
29. Use of licensed medicines for unlicensed applications in psychiatric practice. Council Report CR142. London: Royal College of Psychiatrists; 2007.